Resmed Inc. RMD

NYS: RMD | ISIN: US7611521078   24/04/2024
183,78 USD (-0,24%)
(-0,24%)   24/04/2024

15 maart 2024 · ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis · Persbericht

9 november 2023 · ResMed Adopts New Operating Model to Accelerate Long-term Growth · Persbericht

6 oktober 2023 · Thinking about trading options or stock in Apple, Super Micro Computer, Pioneer Natural Resources, Shoals Technologies Group, or Resmed? · Persbericht

5 juli 2023 · ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software · Persbericht

8 juni 2023 · PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP · Persbericht

25 mei 2023 · 3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023 · Persbericht

2 mei 2023 · ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer · Persbericht

30 maart 2023 · ResMed Chief Administrative Officer and Global General Counsel to Retire · Persbericht

13 maart 2023 · ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep · Persbericht

26 januari 2023 · ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus · Persbericht

22 november 2022 · ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions · Persbericht

4 september 2022 · Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports · Persbericht

28 juni 2022 · ResMed Promotes Lucile Blaise to President, Sleep & Respiratory Care · Persbericht

14 juni 2022 · ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions · Persbericht

25 mei 2022 · ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference · Persbericht

18 mei 2022 · Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study · Persbericht

5 mei 2022 · ResMed Announces Leadership Change · Persbericht

28 april 2022 · ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022 · Persbericht

27 april 2022 · ResMed Announces Participation in the 24th Annual Macquarie Australia Conference · Persbericht

7 april 2022 · ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022 · Persbericht

Mijn selecties